Summit Therapeutics Executive Acquires Shares Amid Market Volatility
Summit Therapeutics Inc. (NASDAQ:SMMT) reported that Chief Operating Officer and Chief Financial Officer Manmeet Singh acquired 50,000 shares of common stock on June 4, 2026, valued at $722,250. The transactions occurred at prices between $14.43 and $14.46 per share. This purchase comes as Summit's stock trades near its 52-week low of $13.83, with …